TECH OFFERS

Dementia, particularly Alzheimer's disease, is a significant socioeconomic burden in aging societies. Traditional blood tests are unable to  detect Alzheimer's biomarkers despite that the biomarkers appear 10-20 years before the appearance of cognitive decline symptoms. A groundbreaking ultrasensitive blood biomarker detection technology has been developed to overcome this limitation. This patented technology detects disease biomarkers at femtogram (fg/mL) levels, achieving sensitivity over 10,000 times higher than conventional methods. In addition to advanced biomarker detection, a comprehensive lifelog data collection technology has been integrated. Using smart rings and other wearable devices, extensive lifelog data is gathered, including sleep patterns, activities, and urine test results. This multimodal data collection supports the creation of the world’s largest Asian Senior Cohort, targeting over 30,000 individuals for the next 5 years. A key component of this innovative approach is the AI-based data analysis for the diagnosis and prognosis of dementia and cognitive dysfunction. AI algorithms analyze the comprehensive datasets, providing precise diagnostic insights and predicting disease progression. This AI-driven analysis, combined with ultrasensitive biomarker detection and detailed lifelog data, forms a robust data platform for early diagnosis, continuous monitoring, and personalized healthcare solutions. By focusing on these cutting-edge technologies, this platform offers a holistic and precise approach to managing cognitive health in super-aging societies. This innovative solution supports precision medicine and provides a comprehensive method for the early detection and ongoing management of dementia and other age-related diseases. This technology offers substantial improvements over current cognitive health management practices through several unique features: Ultrasensitive Biomarker Detection: Unlike conventional methods, which often lack sensitivity, this technology detects Alzheimer's biomarkers at femtogram (fg/mL) levels. This capability enables detection up to decades before cognitive symptoms manifest, facilitating early intervention and significantly improving treatment outcomes. Comprehensive Lifelog Data Integration: Utilizing smart rings and wearables, the technology continuously gathers detailed lifelog data such as sleep patterns and physical activities. This holistic monitoring approach provides a comprehensive view of an individual's health status, enabling personalized healthcare strategies tailored to specific patient needs. AI-Driven Precision Healthcare: Integrated AI algorithms analyse multimodal datasets with over 90% accuracy for diagnosing and predicting cognitive dysfunction. This AI-driven analysis enhances diagnostic precision, monitors disease progression effectively, and optimizes treatment plans based on real-time data insights. Establishment of Large-Scale Research Cohorts: The technology facilitates the creation of extensive Asian Senior Cohorts, supporting longitudinal studies and clinical trials. This infrastructure is pivotal for advancing research in drug discovery, validating biomarkers, and developing innovative medical devices aimed at enhancing dementia management. This integrated technology revolutionizes cognitive health management in aging societies by combining ultrasensitive biomarker detection, comprehensive lifelog data collection, and precise AI-driven analysis for proactive healthcare solutions.  Early Diagnosis: The technology's ultrasensitive biomarker detection enables early identification of Alzheimer's disease, potentially decades before symptoms appear. This early detection supports timely interventions, improving treatment outcomes and quality of life for patients. Continous Monitoring and Personalized Care: Integrating lifelog data from smart devices allows for personalized healthcare strategies tailored to individual health profiles and the continuous monitoring of daily activities, sleep patterns, and vital signs facilitates proactive management and optimization of treatment plans based on real-time data insights.  Tailored Treatment Strategies:  AI-driven analysis of multimodal datasets provides valuable insights into disease progression and treatment efficacy. This capability aids healthcare professionals in monitoring cognitive decline, adjusting therapeutic approaches, and delivering timely interventions to enhance patient care outcomes. Research and Development Platform: The establishment of a large-scale Asian Senior Cohort and extensive lifelog data collection creates opportunities for advanced research in drug discovery, biomarker development, and validation of medical devices. This platform supports longitudinal studies and clinical trials, offering a robust framework for investigating correlations between biomarkers, lifestyle factors, and cognitive health outcomes The market potential for this technology is substantial, driven by the increasing prevalence of dementia and the growing elderly population globally. The Alzheimer's Disease International estimates that over 50 million people worldwide currently live with dementia, with numbers projected to nearly triple by 2050. This demographic shift underscores the urgent need for innovative technologies that can improve early detection, management, and treatment outcomes. This technology's unique value proposition lies in its groundbreaking sensitivity in biomarker detection which allows for early detection of cognitive decline and dementia much earlier than presentation of clinical symptoms. Integrated lifelog allows for a holistic monitoring approach which provides a comprehensive view of an individual's health status, enabling personalized healthcare strategies tailored to specific patient needs. In addition, integrated AI algorithms analyse multimodal datasets with over 90% accuracy for diagnosing and predicting cognitive dysfunction. This AI-driven analysis enhances diagnostic precision, monitors disease progression effectively, and optimizes treatment plans based on real-time data insights. Lastly, the technology provides an opportunity for the creation of extensive Asian Senior Cohorts, supporting longitudinal studies and clinical trials. This infrastructure is pivotal for advancing research in drug discovery, validating biomarkers, and developing innovative medical devices aimed at enhancing dementia management. Dementia, Biomarkers, Alzheimers, Diagnositcs, AI, Precision Health, Personalised Healthcare Healthcare, Diagnostics, Telehealth, Medical Software & Imaging, Pharmaceuticals & Therapeutics

Singapore is an aged society and is set to be “super-aged” in 2026. This means that 21% of the population are 65 years and above. In a recent study conducted in Singapore, 72% had some form of cognitive impairment. The number of young onset dementia is also on the rise in Singapore. This underscores the critical need for early detection and intervention. However, existing screening tools for dementia have limitations. Their ability to identify Mild Cognitive Impairment (MCI), an early stage of dementia, is limited. Additionally, these tools require specialized instructors for test administration and scoring, which can be inconvenient for seniors who must visit a facility for screening. This innovative app merges mobile technology with artificial intelligence to address these challenges. It outperforms the MMSE (mini-mental state examination), the most widely used dementia screening test, in identifying both Alzheimer’s disease and MCI. Furthermore, the AI-based automatic scoring system provides test results within one minute, eliminating the need for specially trained instructors. This feature makes the app accessible anywhere, including at home. By enhancing the accuracy, accessibility, and usability of dementia screening, the app aims to facilitate equitable access to essential healthcare resources and contribute to the well-being of individuals and communities.     The app screens for Alzheimer's disease and Mild Cognitive Impairment (MCI) early by analyzing the user's speech. First, the application begins by collecting speech data from the users answering 11 questionnaires measuring each cognitive ability such as short-term memory and numeracy. Second, the recorded speech files are converted into images using spectrogram generation. Spectrograms convert audio signals into visual representations that show the frequency and intensity of sound over time. This conversion enables the application to capture intricate details and patterns within the user's voice that indicate cognitive changes. Third, the heart of the application is its proprietary artificial intelligence (AI) algorithm. This algorithm has been trained on a vast dataset of voice recordings from 1,300 patients through 2 years of clinical studies. It uses deep learning neural networks to identify subtle patterns, variations, and anomalies in the generated imag­­es. Fourth, the AI algorithm analyzes the images to detect specific patterns associated with Alzheimer's and MCI. These patterns include irregularities in pitch, tone, rhythm, pauses, and other vocal attributes that reveal cognitive decline. Through voice-to-image conversion and a proprietary AI algorithm, the app offers a promising avenue for early diagnosis and proactive management of cognitive health. The app is tailored for the senior healthcare market with two distinct versions: The first version targets the B2B2C healthcare market, focusing on providers of senior care products and services in both public and private sectors. This version operates independently of medical oversight and does not offer disease diagnosis or numerical health assessments. This will be positioned as a cognitive health monitoring tool to empower care providers to enhance their offerings in the senior care market. The second version is a medical device intended for the B2H channel, including hospitals, clinics, and health check-up centres. This version is currently in the process of obtaining certification from the relevant medical device regulatory authority, such as K-FDA. Once certified, the app can complement or replace existing dementia diagnostic tools such as MMSE and CIST. This capability allows hospitals to expand their range of dementia diagnostic services and generate additional revenue from cognitive health assessments, addressing a gap in the current market offerings. Dementia is not solely a concern in South Korea but a global challenge. The number of global dementia patients is anticipated to rise from 55 million in 2020 to 139 million by 2050. Some studies even suggest that this figure may surpass 152 million, three times the current number, by 2050 (Washington University School of Medicine's Institute for Health Metrics and Evaluation, 2021). The market size is expected to continue growing with an average annual growth rate of 12.8% over the next six years. The app pioneers a meticulous approach to cognitive health assessment through acoustic analysis. Unlike traditional methods that rely solely on user responses, it analyses factors such as word intervals, pauses, and pitch variations. This detailed acoustic perspective enables it to detect early signs of cognitive decline, surpassing the limitations of conventional techniques. Central to innovation is a language-independent algorithm. It effortlessly converts user speech into spectrogram images that vividly depict speech characteristics using colour and brightness variations. This approach breaks down language barriers, adapting seamlessly to diverse linguistic contexts without requiring new algorithms for each language. This adaptability ensures the app serves global communities effectively. Designed for accessibility and convenience, the app completes screening in just 10-15 minutes using a mobile device—no specialised equipment necessary. This simplicity empowers seniors and caregivers, democratizing proactive health management. The app's portability and user-centric design redefine dementia screening, offering innovative features and universal accessibility that set a new standard in cognitive health assessment. Healthcare, Telehealth, Medical Software & Imaging

The company offers a suite of innovative automated liquid handling systems, hardware and software for process automation designed to enhance precision, efficiency, and scalability in biological research. The industry currently faces significant challenges with semi or full automation of laboratory equipment, including high costs, limited flexibility, and manual errors. These bottlenecks hinder the efficiency and reliability of complex laboratory processes. The company's technology addresses these issues with a range of flagship products that provide cutting-edge automation for tasks such as genomic and proteomic analysis, drug discovery, and clinical diagnostics. The systems feature modular assembly, allowing for easy customization and scalability to meet the evolving needs of life science laboratories. This flexibility ensures that the solutions can adapt to various experimental setups and requirements. One of the unique value proposition of the company's technology is its ability to significantly reduce costs up to 90% compared to traditional automation systems. This cost-effectiveness is achieved through innovative mechanical design, advanced software integration, and efficient hardware utilization. Additionally, the systems boast the largest consumables library in the industry, providing researchers with a wide range of options to support their specific needs. The company is actively seeking software and OEM partnerships to further enhance its product offerings and expand its market reach. By collaborating with key partners, it aims to continue driving innovation and providing top-tier solutions to the life sciences industry. The product range includes modular automated liquid handlers, hardware and software engineering that can be customized for a variety of laboratory applications. Key features include: Precision Pipetting: Capable of handling small volumes with high accuracy. User-Friendly Software: The software interface allows for easy programming and integration with existing lab protocols without the need for extensive technical knowledge. Scalable Design: Modular components enable easy expansion and adaptation to changing research needs. Compatibility: Seamless integration with other laboratory instruments and workflows. Industry: Pharmaceuticals, Biotechnology, Clinical Research, Academic Research. Applications: High-throughput Screening, Drug Development, Clinical Diagnostics, Production, Quality Control, PCR Preparation, Protein Purification, Nucleic Acid Extraction, Diagnostic Sample Preparation, NGS Library Preparation, Serial Dilution, Cell-based Assay, ELISA, Aliquoting. Products: Automated liquid handlers, No-code lab automation software, Customizing for OEM/OEM process automation. The global market for liquid handling systems is expected to reach $3.6 billion by 2027, driven by increasing demand for automation in the life sciences sector. Significant growth opportunities exist in North America, Europe, and Asia, with a focus on applications in drug discovery and clinical diagnostics. The lab automation solutions provide unmatched precision, reliability, and flexibility at a competitive price. Lab automation solution minimizes human error, increases experimental reproducibility, and supports scalable research workflows, making it ideal for laboratories looking to enhance their operational efficiency and data integrity. Enhanced Precision: Reduces manual errors by up to 99%, ensuring reliable and reproducible results. Advanced pipetting technology for accurate liquid handling. Increased Throughput: Automates repetitive tasks, allowing for a 50% increase in sample processing rates. Streamlines workflows to reduce manual labor. Cost Efficiency: Reduces costs by up to 90% compared to traditional automation systems. Innovative mechanical design and modular components save an average of $50,000 per year in operational costs. Modular Assembly: Allows for easy customization and scalability to meet specific laboratory needs. Flexible design that can adapt to various experimental setups and requirements, reducing setup time by 70%. User-Friendly Software: Advanced software for intuitive operation, reducing training time by 60%. Drag-and-drop interface for easy protocol setup and modifications, enabling setup changes in under 5 minutes. Collaboration: Consultative lab automation system ODM/OEM partnership from ideation, concept design, product validation and product commercialization. Ability to provide fully automated solutions including consulting, hardware, software and 3rd party integration. Automated Liquid Handling, Laboratory Automation, Clinical Diagnostics, High-Throughput Screening, Automation Robots, Pipetting, Biofoundry, Cell Line Development, Drug Discovery, Genotyping Healthcare, Diagnostics, Pharmaceuticals & Therapeutics, Manufacturing, Assembly, Automation & Robotics, Life Sciences, Industrial Biotech Methods & Processes

Unsafe and contaminated food poses significant global health risks, affecting approximately one in ten people worldwide and leading to economic losses of around $110 billion annually in low and middle-income countries due to reduced productivity and medical expenses. This issue also accounts for an annual burden of 33 million disability-adjusted life years and causes about 420,000 premature deaths. Additionally, the escalating use of pesticides in food production to meet the demands of a growing population contributes to approximately 200,000 deaths each year due to toxic exposure, posing severe threats to both human health and the environment.  This technology, Plasma Activated Water (PAW) provides an eco-friendly, chemical-free decontamination technique which eradicates residual chemicals, inhibiting microbial growth in agricultural produce. The technology is highly effective (95% reliability) in breaking down organic compounds, including pesticides, and destroying microbial pathogens on the surfaces of fruits and vegetables, resulting in an extended shelf-life.  PAW eliminates the need for potentially toxic chemicals for washing, minimizes chemical residues, reducing environmental impact and agricultural losses, thereby lowering costs. It effectively degrades pesticides, enhancing food safety while maintaining nutritional quality and sensory qualities.   The technology owner is seeking collaborations with agricultural companies or Institutes of Higher Learning to test-bed their technology.  Plasma Activated Water (PAW) is an innovative technology that harnesses the reactive properties of plasma to enhance the characteristics of water. The process involves generating an electrical discharge in a gaseous environment, creating a plasma rich in reactive oxygen and nitrogen species (RONS). The use of pin-hole technology allows for precise and controlled plasma generation at the required intensity and location. This technique involves creating a small, focused plasma jet through a pin-hole or narrow aperture, which directs the plasma stream accurately to the target area. This precision ensures effective application, reducing the risk of unintended exposure and increasing treatment efficacy. The focused nature of the plasma jet also minimizes diffusion, resulting in more efficient energy use and lower operational costs. The reactive species interact with the surface of agricultural produce, they effectively deactivate or destroy pathogens, bacteria, and pesticide residues. PAW technology significantly enhances food safety by reducing contaminants in produce by over 50-80%, compared to just 30% with standard water washes.  This technology has the potential to transcend agricultural applications, harnessing its pathogen- and bacteria-destroying capabilities.  Healthcare and Medical Sector: Can be used to irrigate wounds, leveraging its strong antimicrobial properties to clean and disinfect wound sites, promoting faster healing and preventing infections Industrial Wastewater Treatment: To treat industrial wastewater by breaking down pollutants and pathogens, ensuring that the treated water meets environmental regulations  Superior Decontamination Efficiency: Highly Effective: PAW technology significantly reduces contaminants, achieving over 50-80% reduction in pathogens and pesticide residues compared to just 30% with standard water washes. Its decontamination efficiency stands at 95% reliability Broad-Spectrum Antimicrobial Action: PAW effectively eliminates a wide range of microorganisms, including bacteria, viruses, and fungi, providing comprehensive protection Eco-Friendly and Chemical-Free: Minimized Chemical Use: Unlike traditional methods that rely heavily on chemical disinfectants, PAW uses plasma to activate water, significantly reducing the need for potentially harmful chemicals Harmless Byproducts: The reactive oxygen and nitrogen species (ROS and RNS) generated by PAW break down into harmless byproducts, such as water and nitrogen, making it environmentally friendly Environment, Clean Air & Water, Sanitisation, Foods, Quality & Safety, Sustainability, Food Security

With the advent of the intelligent era, data has become the core asset of enterprises. Simultaneously, remote work and multi-branch collaboration have emerged as new work modes. Many enterprises urgently need a cybersecurity solution that can ensure data security and improve work efficiency to deliver quality services and enhance competitiveness. Traditional enterprise security measures impose various restrictions on employees’ use of software and hardware and limit access to third-party partners, such as prohibiting access to personal computers and requiring the installation of multiple access endpoints. These restrictions generate several problems to the enterprises, such as complex usage, inadequate security defense capabilities, and high operating costs. To address these issues, the technology owner has launched an innovative enterprise security browser designed to solve security challenges in remote work and multi-location collaboration while optimizing the employee working experience. This enterprise security browser features a lightweight design, is easy to install, and seamlessly integrates into employee workflows without requiring modifications to existing software and hardware. Additionally, it employs a series of dynamic security strategies to enable find grain control over data leakage and user privacy protection, achieving effective and intelligent enterprise data security management. The technology owner is actively seeking partnership with companies with multiple employee identities in the financial and internet sectors, to co-develop and deploy this innovative enterprise security browser. Such collaboration will enable both parties to push the frontiers of data security and offering robust support for the digital transformation of enterprises. This innovative browser, built on Chromium and deeply integrated with a zero-trust safety classifier, prioritizes both safety and efficiency, significantly improving the user experience and employee performance and enhancing the data security protection loop in multiple enterprise scenarios. Reliable Access: dynamically secures enterprise access from multiple dimensions such as access, identity, device, access, and data, ensuring comprehensive security Data Desensitization: utilise identity-based data access control and granular data desensitization to prevent data leakage through techniques such as character masking and sensitive content blocking, realising a personalized display for different users Behavior Management: control behaviors such as anti-copying, anti-printing, and anti-screenshot, migrating the risk of information leakage by ensuring files not landing on local hard drives Security Visibility: offers comprehensive logging and auditing of user access, behaviors, and threat alarms, facilitating easy traceability and thorough auditing Perfect Experience: requires no hardware for rapid deployment and hassle-free replacement. Maintains a familiar interface for a seamless transition, low learning curve, and high efficiency The technology owner leverages zero-trust security concept to offer comprehensive security management, making it ideal for sectors like finance, e-commerce, and manufacturing that require remote work and multiple branch operations, as well as industries that requires robust data security. Potential application scenarios include: Third-Party Secure Collaboration: guarantee secure data access for industry chain collaborators Remote Secure Access: ensure safe access from anywhere, supporting hybrid work modes IE Restriction Management: transition from IE to a dual-core browser, enabling access to IE-restricted sites Data Leakage Protection: multiple desensitization templates and security controls VDI Replacement: a cost-effective and low-maintenance alternative to VDI VPN Enhancement: by replacing with a more secure browser-based solution Identity access security: continuous verification and precise access control Whole-link data security: automated desensitization, encryption and behavior controls Dynamic verification and defense: adapts security based on behavior analysis Cost-effective: low-cost, easy installation and user-friendly Data security, Remote Work, Cyber Security Infocomm, Security & Privacy, Enterprise & Productivity

The demand for improved healthcare, coupled with increasing life expectancy and a growing elderly population, alongside resource constraints, necessitates the implementation of a 24/7 remote monitoring system equipped with an accurate risk prediction process. This process should forecast potential risks for individuals, enabling early detection and remote alerts to promptly alert healthcare providers and individual caregivers, thereby enhancing the well-being of those under care. A Japanese technology owner has developed a Time-of-Flight (ToF) sensor technology, characterised by executing a risk prediction process to predict risks for the monitored individuals based on presence range and posture.  Unlike conventional camera-based systems, the proposed technology emphasises the privacy of the monitored individual by abstaining from capturing actual photos or images. Through the implementation of a proprietary artificial intelligence (AI) algorithm, it can discern whether the individual under observation is absent from the bed, lying flat on it, sitting at its edge, or lying on the floor next to the bed. A web-based user interface had been developed to provide healthcare professionals various degrees of warning, e.g., patient at safe zone, gray zone, caution zone or bed edge zone. The technology owner is looking to work with healthcare providers, agencies or developers providing housing for the elderly, or technology companies for test bedding trials, as well as research and development collaborations to customise the technology for specific use cases. The technology leverages time-of-flight (ToF) sensors, which gauge distances between the sensor and the subject for each point in the image based on the round-trip time of an artificial light signal emitted by a laser. The process commences with the capture of an image of the individual, subsequently transmitted wirelessly via Wi-Fi to central management software. Equipped with algorithms, this software discerns any movement beyond predefined boundaries, such as within a hospital bed setting. Positioned above the bed, ToF sensors ascertain the person's position, whether lying down, seated on the bed's edge, or standing beside it. The resultant data is transmitted to a dedicated server situated at a nurse or helper station, where professionals like nurses or caregivers operate. The ToF sensor is positioned at a height of 2.5m, effectively covering a 2m x 2m area. The sensor detects height variations by displaying different colours and shapes on the software's graphical squares. Additionally, the system conducts an analysis of the individual's spatial orientation and vertical displacement, aiding in the evaluation of their overall condition. Visual representations typically depict lighter hues denoting proximity to the sensor, while darker shades indicate areas further away, such as the floor. Patient/ Elderly Fall Management: Healthcare Monitoring: Monitoring patients in hospitals or nursing homes to track their movements, position changes, and overall well-being without compromising their privacy. Elderly Care: Assisting caregivers in monitoring elderly individuals living independently at home to ensure their safety and well-being, particularly for those at risk of falls or other health issues. The technology can be adapted to be used for object tracking, human presence detection, etc. The technology is low-cost and low-power consumption, lightweight, and easy to install. The UVP includes: Privacy Emphasis: Prioritizing privacy by avoiding actual image capture while still providing effective monitoring. Unlock greater data potential: System firmware/software maximizes TOF sensor data, extracting unparalleled value. Visualization and Analysis: Utilizes graphical representations and AI/ ML algorithms to visualize and analyze data, aiding professionals in evaluating an individual's condition and making informed decisions. Real-time Alerts: Provides real-time alerts to professionals, such as nurses or caregivers, enabling prompt responses to any detected abnormalities or movements outside predefined boundaries. System Extension: ToF sensors can be easily added into the existing hardware and software system, minimizing implementation costs and disruption. Healthcare, Wellness, Fall Detection, Time-of-Flight sensor, AI algorithm Infocomm, Video/Image Analysis & Computer Vision, Wireless Technology, Healthcare ICT

With the recent trend of digital transformation in government and corporate sectors, there is a specific focus on creating solutions that utilize AI to enhance decision-making, streamline operations, and foster interaction across various platforms. The challenge however involves leveraging private data to train AI models that are not only efficient but also secure and capable of handling complex, industry-specific tasks, thereby promoting operational efficacy and strategic growth. This technology utilizes an advanced AI-driven platform, designed to facilitate digital transformation and provide intelligent content creation with resource optimization services through the processing, analysis, and application of multimodal data to meet the needs of specific industries. It capitalizes on private data to train specific AI models, enhancing decision-making capabilities and operational efficiency. The platform encompasses AI digital humans, intelligent terminals, and targeted AI management systems, aiming to streamline interactions and manage diverse tasks across various industries with a focus on customized, real-time solutions. This approach promises a significant boost in productivity and operational effectiveness through data-driven insights and AI integration.   The technology consists of four key components: AI digital human cloud platform, embodied intelligent terminals, target AI management, and an industry-specific digital brain. It utilizes private data to train vertical AI models, ensuring enhanced data-driven decision-making and operational efficiency. The system features multi-system collaborative integration, enhanced intention understanding, and private data learning. It also integrates behavior-based learning and embodied intelligence, which continuously evolve to meet complex, real-time business needs across various sectors. Other features include: Private data learning Enhanced intention understanding Behavior-based learning Continuous building of embodied intelligence Multi-system collaborative integration The technology has diverse potential applications across different sectors: 1. Government and Corporate Digitalization: Enhances decision-making and efficiency through AI-driven data analysis and management solutions. 2. Healthcare and Education: Implements AI digital humans to interact and provide specialized information and services. 3. Customer Service: Uses AI digital humans for real-time customer support across various industries. 4. Human Resources: Automates and optimizes recruitment, training, and performance evaluations with AI insights. 5. Marketing and Sales: Employs intelligent systems to manage customer relationships and optimize marketing strategies. 6. Manufacturing and Logistics: Facilitates smart factories and supply chains through predictive analytics and real-time monitoring.    The unique value proposition of this technology lies in its integration of AI with specific vertical models tailored to different industries, enabling a higher level of customization and precision in data processing and decision-making. Key benefits include: Enhanced Data Privacy: Utilizes private data learning, ensuring secure data handling and customized AI training without compromising confidentiality. Improved Decision Making: Leverages decision intelligence and cognitive intelligence to provide real-time, data-driven insights that enhance operational decisions. Seamless Integration: Offers multi-system collaborative integration, allowing for easy adoption within existing IT infrastructures and processes, reducing the complexity and cost of technology deployment. Continuous Innovation: Features continuous building of embodied intelligence, enabling adaptive and evolving AI capabilities that keep pace with industry changes and demands.   Infocomm, Artificial Intelligence

The core technology is of a formulation that is an effective natural water based iodine multi-pathogenic solution that is designed to destroy various pathogens quickly. Although, the active ingredients are present at low levels, this formulation has been successfully demonstrated to provide protection and is registered for use as a chemical disinfectant.  The IP involves the creation of a formulation that is novel in having a different and versatile broad spectrum ability to destroys different pathogens and their accompanying cellular survival structures simultaneously and quickly. It functions using diverse mechanisms of action via oxidative and complexation reactions. Additionally, multiple prongs of attack leave little time to mount or develop resistance mechanisms, potentially hindering chances of resistant strains emerging.  It is anticipated that it would be widely used in a variety of settings for personal care and health care applications. Users to date have reported its successful application on a wide range of use cases e.g. for oral use, skin care, wound healing and as disinfectants. The technology owners are seeking partners to carry out test-bedding the various consumer claims in clinical trials, as well as carry as R&D collaboration to further explore new applications. They are also seeking partners who would be able to quickly manufacture and distribute our formulation. The active ingredients are naturally derived and are present at extremely low concentrations (following UN food safety guidelines). Safe and non-toxic, with ingredients that are largely not alien to the human body. The formulation effective targets various types of pathogens simultaneously ,using different mechanisms depending on the pathogenic species involved. It causes severe oxidative damage to chemical structures on various pathogens, affects multiple target structures within micro-organism eg enzymes, membranes, other essential cellular survival components simultaneously.  The potential applications are in the realm of personal care and general healthcare. The technology is registered for use as a chemical disinfectant for oral use and consumers have reported other off-label uses for different ailments notably non-exhaustive such as: Quickly alleviating symptoms of coughs, sore throats, colds Cleans, disinfect wounds, cuts, abrasion Promote wound healing by preventing infections eg burns, deep wounds, leaving minimal scarring and thus allowing the skin to be restored to its natural smoothness and texture Topical applications on skin e.g. eczema, acne (reduces bacterial infections quickly, leaving minimal or no scarring Dental application: mouth odors control and mouth ulcers Effective smell removal eg fishy, putrid odours  The unique value proposition of our formulation is that it has anti-viral, anti-bacterial and anti- fungal properties. It is able to confer anti-inflammatory effects thus allowing the body’s immune system to act effectively allowing its natural healing process to take place. During the recent pandemic, consumers have shared anecdotal evidence for its rapid and successful use on both a host of different gram positive and gram negative bacteria and on various strains of the Covid-19 virus. The fast speed of these reactions to destroy and disrupt the structures of pathogens severely as well as its accompanying survival structures creates hostile/challenging environment for survival and resistance. These multiple prongs of attack (unlike antibiotics tend to target specific biochemical pathways or biological structure) leave little time to mount or develop resistance mechanisms, hindering chances of resistant strains emerging. The formulation is eco-friendly and naturally biodegradable which allows for its use in emergency water disinfection andi is least harmful to aquatic life and ecosystems. Generally it would be expected to more cost effective compared to other types of disinfection methods as we require smaller amounts of final product and use inexpensive raw materials for the formulation.  broad spectrum, rapid action, iodine, safe and non-toxic solution, halal friendly disinfectant, anti-pathogenic Healthcare, Pharmaceuticals & Therapeutics, Life Sciences, Biotech Research Reagents & Tools, Chemicals, Organic

Many vascular procedures such as central venous catheter insertion, dialysis catheter insertion, arterial angiograms, etc requires a skilled personnel to complete the task. A fistula used for example, in haemodialysis, is a direct connection of an artery to a vein. Once the fistula is created it is a natural part of the body. When the fistula properly matures, it provides an access with good blood flow that can last for decades. The gold-standard for access is an AV fistula. The success of an AV fistula procedure and vascular cannulation procedures depend on the skill of the medical professional. Potential difficulties during the procedure include: Multiple venepunctures attempts before successful cannulation Accidental puncture of the front vessel wall due to deep insertion Accidental puncture of the opposite side of the vessel wall while inserting the needle further upstream Inadvertent punction of the opposing vessels. Endovascular surgeons, therefore, need an improved device for penetrating the vessel wall during cannulation procedure. This technology is of a smart needle which can reliably gauge the intravascular position of distal end of the needle and detect vessel wall penetration. The device protects against needlestick accidents and accidental back walling of fistula wall.​ It avoids accidental puncturing of the opposing vessel wall and prevents accidental back-walling during the cannulation procedure by automatically deploying a smart sensing stylet after successful needle puncture of vessel wall. The technology owner is seeking for medical device manufacturers, clinical collaborators, and independent dialysis centres to conduct first-in-human studies. The proposed smart vessel wall penetration detection system consists of a spring actuated smart sensing stylet to prevent accidental back walling of the fistula wall during cannulation, and a flashback chamber to gauge the intravascular position of the needle during puncture. The trigger engages the said stylet, during the cannulation process to shield/retracting and expose/release the needle respectively. Two haemostasis valves are incorporated into the device: one located at the trigger housing to prevent blood leakage into said trigger; the other in the catheter housing to reduce and prevent blood leakage during needle removal. Both needle and said stylet will be removed from the device while retaining the flexible catheter tube inside the fistula to proceed with the dialysis session In summary, the proposed system has these key features: Smart sensing stylet is in extended mode prior to use to protect user from accidental needlestick compared to conventional fistula needles. Sensing means (flashback chamber) to gauge the intravascular position of the distal end of the needle. Spring actuated trigger that conceals smart stylet to enable puncture of fistula wall followed by automatic propulsion of said stylet upon release of trigger. Removable needle and said stylet to provide a safer and more comfortable dialysis session.  This technology can be applied to endovascular procedures such as AV fistula cannulation, central venous catheter insertion, dialysis catheter insertion, arterial angiogram. The global A.V. Fistula Needles market size alone was valued at USD 191.4 million in 2022 and is forecast to a readjusted size of USD 312.9 million by 2029 with a CAGR of 7.3% during review period. The growing worldwide incidence of End Stage Renal disease is expected to drive the demand for dialysis treatment, and thereby the need for safer, smarter AV Fistula needles. Globally, it is expected that around 2 million people are affected with ESRD each year (Source: USRDS Annual Data Report (2021). The global hemodialysis market in terms of revenue was estimated to be $76.9Bn in 2021 and is poised to reach $105.1Bn in 2026 with a CAGR if 6.4%. APAC markets such as China, India, Japan and Singapore are expected to offer significant growth opportunities for players in the hemodialysis market. Taiwan and Malaysia have the highest incidence of ESRD in 45-65 and > 75 age group as per US Renal Data System (2020 Annual Report) A smart needle that enables physicians have better control of the cannulation procedure and gauge the intravascular position of the distal end of the needle. Provide safer cannulation procedure to patients by preventing accidental punctures and back-walling of vascular vessels Provide a more effective fistula cannulation by avoiding puncture complications, which enables patients to have a more comfortable dialysis session smart fistula, smart needle Healthcare, Medical Devices